Rasburicase-Induced Falsely Low Measurement of Uric Acid in Tumor Lysis Syndrome: A Report of Two Cases

Rasburicase, a recombinant urate-oxidase enzyme, can significantly catalyze the oxidation of uric acid to allantoin. It was approved by the US Food and Drug Administration (FDA) to control blood uric acid levels in both pediatric and adult patients especially those with tumor lysis syndrome. It is q...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Lian, Xie, Yinjing, Ma, Jiangtao, Li, Guoqiang, Yuan, Xiaopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Medical Education
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981216/
https://www.ncbi.nlm.nih.gov/pubmed/36874663
http://dx.doi.org/10.7759/cureus.34435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981216/
https://www.ncbi.nlm.nih.gov/pubmed/36874663
http://dx.doi.org/10.7759/cureus.34435

Ejemplares similares